Fig. 6
From: METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis
Correlation between METTL7B expression and immune checkpoint molecule expression
Fig. 6 | Cancer Cell International
From: METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis
Correlation between METTL7B expression and immune checkpoint molecule expression